Pharmaceutical Preparations, Challenges in Formulations and Compatibility Studies

A special issue of Pharmaceuticals (ISSN 1424-8247). This special issue belongs to the section "Pharmaceutical Technology".

Deadline for manuscript submissions: closed (25 April 2024) | Viewed by 2813

Special Issue Editors

1. Institut d’Investigació Biomèdica Sant Pau (IIB SANT PAU), Barcelona, Spain
2. Pharmacy Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
3. CIBER de Enfermedades Raras (CIBERER), Instituto de Salud Carlos III, Madrid, Spain
Interests: pharmacology; stability studies; precision medicine

E-Mail Website
Guest Editor
Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
Interests: parenteral nutrition; stability studies; nutrition support
1, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
2. Faculty of Health Science, Blanquerna – Universitat Ramon Llull, Barcelona, Spain
Interests: stability studies; pharmacotherapy; pharmaceutical care

Special Issue Information

Dear Colleagues,

Compounding pharmacists have always worked to ensure the stability and safety of the compounds they produce, as well as the effectiveness of drugs administered to patients. Several factors can affect the stability of compounded medications, such as heat, light, oxidation or hydrolysis.

In daily routine, pharmacists face some challenges when they have to assess the stability and/or compatibility of drugs in different vehicles. Sometimes there is a lack of information, particularly for novel drugs or new in-house preparations. In the hospital setting, especially for critical care patients, there may be risky situations when the co-administration of drugs or TPN–drug through the same line is required, and no information about their stability is available.

In this sense, further studies are needed to generate more evidence regarding the abovementioned challenges and to increase the knowledge in this area. In this Special Issue, we aim to compile research from experts in the field that focuses on the concerns affecting preparations.

Dr. Pau Riera
Dr. Jan Thomas De Pourcq
Dr. Noe Garin
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • stability
  • sterility
  • drug–TPN and drug–drug compatibility
  • formulation challenges

Published Papers (2 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

Jump to: Review

12 pages, 2743 KiB  
Article
Exploring Immersion Coating as a Cost-Effective Method for Small-Scale Production of Enteric-Coated Gelatin Capsules
by Beatrice Sabbatini, Diego Romano Perinelli, Giovanni Filippo Palmieri, Marco Cespi and Giulia Bonacucina
Pharmaceuticals 2024, 17(4), 433; https://0-doi-org.brum.beds.ac.uk/10.3390/ph17040433 - 28 Mar 2024
Viewed by 567
Abstract
The coating process for solid dosage forms is widely used in the pharmaceutical industry but presents challenges for small-scale production, needed in personalized medicine and clinical or galenic settings. This study aimed to evaluate immersion coating, a cost-effective small-scale method, for enteric-coated gelatin [...] Read more.
The coating process for solid dosage forms is widely used in the pharmaceutical industry but presents challenges for small-scale production, needed in personalized medicine and clinical or galenic settings. This study aimed to evaluate immersion coating, a cost-effective small-scale method, for enteric-coated gelatin capsules using standard equipment. Two enteric coating polymers and different polymer concentrations were tested, along with API solubility. Results were compared with commercially available enteric capsule shells. Successful preparation of enteric coating capsules via immersion necessitates a comprehensive grasp of API and enteric polymer behavior. However, utilizing commercially available enteric capsule shells does not guarantee ease or robustness, as their efficacy hinges on the attributes of the active ingredient and excipients. Notably, coating with Eudragit S100 stands out for its superior process robustness, requiring minimal or no development time, thus representing the best option for small-scale enteric capsule production. Full article
Show Figures

Graphical abstract

Review

Jump to: Research

19 pages, 556 KiB  
Review
A Narrative Review: Analysis of Supplemental Parenteral Nutrition in Adults at the End of Life
by Francisco Rivas García, Rafael Jesús Giménez Martínez, Felipe José Huertas Camarasa, Joan Carles March Cerdá, Fuensanta Lloris Messeguer and Margarita López-Viota Gallardo
Pharmaceuticals 2024, 17(1), 65; https://0-doi-org.brum.beds.ac.uk/10.3390/ph17010065 - 30 Dec 2023
Viewed by 1412
Abstract
“End of life” is a stage defined by the existence of an irreversible prognosis that ends with a person’s death. One of the aspects of interest regarding end of life focuses on parenteral nutrition, which is usually administered in order to avoid malnutrition [...] Read more.
“End of life” is a stage defined by the existence of an irreversible prognosis that ends with a person’s death. One of the aspects of interest regarding end of life focuses on parenteral nutrition, which is usually administered in order to avoid malnutrition and associated complications. However, parenteral nutrition can be adapted to specific circumstances and evolve in its functionality through supplementation with certain nutrients that can have a beneficial effect. This narrative review aims to carry out a situation analysis of the role that could be adopted by supplemental parenteral nutrition in attenuating alterations typical of end of life and potential improvement in quality of life. Full article
Show Figures

Figure 1

Back to TopTop